The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Allergic Rhinitis: A Review
Abstract
Importance: Allergic rhinitis affects an estimated 15% of the US population (approximately 50 million individuals) and is associated with the presence of asthma, eczema, chronic or recurrent sinusitis, cough, and both tension and migraine headaches. Observations: Allergic rhinitis occurs when disruption of the epithelial barrier allows allergens to penetrate the mucosal epithelium of nasal passages, inducing a T-helper type 2 inflammatory response and production of allergen-specific IgE. Allergic rhinitis typically presents with symptoms of nasal congestion, rhinorrhea, postnasal drainage, sneezing, and itching of the eyes, nose, and throat. In an international study, the most common symptoms of allergic rhinitis were rhinorrhea (90.38%) and nasal congestion (94.23%). Patients with nonallergic rhinitis present primarily with nasal congestion and postnasal drainage frequently associated with sinus pressure, ear plugging, muffled sounds and pain, and eustachian tube dysfunction that is less responsive to nasal corticosteroids. Patients with seasonal allergic rhinitis typically have physical examination findings of edematous and pale turbinates. Patients with perennial allergic rhinitis typically have erythematous and inflamed turbinates with serous secretions that appear similar to other forms of chronic rhinitis at physical examination. Patients with nonallergic rhinitis have negative test results for specific IgE aeroallergens. Intermittent allergic rhinitis is defined as symptoms occurring less than 4 consecutive days/week or less than 4 consecutive weeks/year. Persistent allergic rhinitis is defined as symptoms occurring more often than 4 consecutive days/week and for more than 4 consecutive weeks/year. Patients with allergic rhinitis should avoid inciting allergens. In addition, first-line treatment for mild intermittent or mild persistent allergic rhinitis may include a second-generation H 1 antihistamine (eg, cetirizine, fexofenadine, desloratadine, loratadine) or an intranasal antihistamine (eg, azelastine, olopatadine), whereas patients with persistent moderate to severe allergic rhinitis should be treated initially with an intranasal corticosteroid (eg, fluticasone, triamcinolone, budesonide, mometasone) either alone or in combination with an intranasal antihistamine. In contrast, first-line therapy for patients with nonallergic rhinitis consists of an intranasal antihistamine as monotherapy or in combination with an intranasal corticosteroid. Conclusions and Relevance: Allergic rhinitis is associated with symptoms of nasal congestion, sneezing, and itching of the eyes, nose, and throat. Patients with allergic rhinitis should be instructed to avoid inciting allergens. Therapies include second-generation H 1 antihistamines (eg, cetirizine, fexofenadine, desloratadine, loratadine), intranasal antihistamines (eg, azelastine, olopatadine), and intranasal corticosteroids (eg, fluticasone, triamcinolone, budesonide, mometasone) and should be selected based on the severity and frequency of symptoms and patient preference.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey
Meltzer, E. O., Blaiss, M. S., Derebery, M. J., Mahr, T. A., Gordon, B. R., Sheth, K. K., Simmons, A. L., Wingertzahn, M. A., & Boyle, J. M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.013 · Cited by 553
Rhinitis 2020: A practice parameter update
Dykewicz, M. S., Wallace, D. V., Amrol, D. J., Baroody, F. M., Bernstein, J. A., Craig, T. J., Dinakar, C., Ellis, A. K., Finegold, I., Golden, D. B. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.007 · Cited by 436
Self-citationDonald, K., & Finlay, B. B. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00874-w · Cited by 354
The biology of dust mites and the remediation of mite allergens in allergic disease
Arlian, L. G., & Platts-Mills, T. A. E. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.113670 · Cited by 323
Overview on the pathomechanisms of allergic rhinitis
Pawankar, R., Mori, S., Ozu, C., & Kimura, S. (2011) · Asia Pacific Allergy · doi:10.5415/apallergy.2011.1.3.157 · Cited by 280
Burden of allergic rhinitis: Allergies in America, Latin America, and Asia-Pacific adult surveys
Meltzer, E. O., Blaiss, M. S., Naclerio, R. M., Stoloff, S. W., Derebery, M. J., Nelson, H. S., Boyle, J. M., & Wingertzahn, M. A. (2012) · Allergy and Asthma Proceedings · doi:10.2500/aap.2012.33.3603 · Cited by 270
Gergen, P. J., Mortimer, K. M., Eggleston, P. A., Rosenstreich, D., Mitchell, H., Ownby, D., Kattan, M., Baker, D., Wright, E. C., Slavin, R., et al. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70477-x · Cited by 219
Home environmental intervention in inner-city asthma: a randomized controlled clinical trial
Eggleston, P. A., Butz, A., Rand, C., Curtin-Brosnan, J., Kanchanaraksa, S., Swartz, L., Breysse, P., Buckley, T., Diette, G., Merriman, B., et al. (2005) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61012-5 · Cited by 213
Update on nonallergic rhinitis
Settipane, R. A., & Lieberman, P. (2001) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62896-7 · Cited by 206
The burden of allergic rhinitis and asthma
Ozdoganoglu, T., & Songu, M. (2012) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465811431975 · Cited by 202
Cited by
Neuroimmune mechanisms of type 2 inflammation in the skin and lung
Tamari, M., & Ver Heul, A. M. (2025) · Allergology International · doi:10.1016/j.alit.2025.02.001 · Cited by 17
Metadata
- Authors
- Bernstein, J. A., Bernstein, J. S., Makol, R., & Ward, S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2024-03-12
- Volume
- 331
- Issue
- 10
- Pages
- 866
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4392702384
- Cited by
- 318
- References
- 46
- FWCI
- 83.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Allergic Rhinitis: A Review. https://app.cochat.ai/papers/10.1001/jama.2024.0530
- The paper
- Bernstein, J. A., Bernstein, J. S., Makol, R., & Ward, S. (2024). Allergic Rhinitis: A Review. JAMA. https://doi.org/10.1001/jama.2024.0530
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.